Heart attack risk assessment company Cardio Diagnostics moves headquarters to Chicago
The company makes the Epi+Gen test that assesses the risk for the onset of new coronary heart disease.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Ben Miller Source Type: news
More News: Biotechnology | Cardiology | Coronary Heart Disease | Health Management | Heart | Heart Attack | Heart Disease